Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) exerts an important role in inflammatory processes, lipids homeostasis, and cardiometabolic disorders that are closely associated with psoriasis. The aim of the study was to analyze the clinical and diagnostic value of serum PCSK9 con...

Descripción completa

Detalles Bibliográficos
Autores principales: Krahel, Julita Anna, Baran, Anna, Kamiński, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230388/
https://www.ncbi.nlm.nih.gov/pubmed/32225075
http://dx.doi.org/10.3390/jcm9040910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230388/
https://www.ncbi.nlm.nih.gov/pubmed/32225075
http://dx.doi.org/10.3390/jcm9040910

Ejemplares similares